Navigation Links
Step to the Plate - Register to Donate Aims to Educate Baseball Fans About the Importance of Organ Donation and Increase Registrations
Date:5/18/2009

DEERFIELD, Ill., May 18 /PRNewswire/ -- As the number of people awaiting lifesaving organ transplants in the United States continues to climb - currently more than 100,000 people are on the waiting list - it is more important than ever for people who support donation to become registered donors. Today, Astellas Pharma US, Inc., in partnership with Donate Life, launches Step to the Plate - Register to Donate, a national campaign to reinforce the importance of organ donation, share stories of those changed by the miracle of transplantation and provide the public with the information they need to join their state organ donation registries.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090518/NY18227)

The program uses the setting of Major League Baseball(TM) (MLB) and Minor League Baseball(TM) (MiLB) games to spread the message that every person has the power to save lives through organ donation. The program also recognizes the important contributions of members of the transplant and donation communities, including recipients, donors, organ procurement organizations, physicians, surgeons and transplant center staff.

"An average of 18 people die each day waiting for available organs. Therefore, it's imperative that we educate people about donation and provide information and access to allow them to register to donate," said Maribeth Landwehr, Director, Corporate Communications for Astellas.

Event activities will include a pre-game ceremony featuring local members of the donation and transplant communities, a special "first pitch" by a local transplant recipient and between-inning contests. Fans will have an opportunity during the game to join their state organ donor registry. Also, the first 500 entrants to the ballpark at each MiLB game will receive a free giveaway featuring the Donate Life and Aste
'/>"/>

SOURCE Astellas
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New study finds Power Plate exercise aids in weight loss, reduction of harmful visceral fat
2. New Study Finds Power Plate(R) Exercise Aids in Weight Loss, Reduction of Harmful Visceral Fat
3. Study: Vibration plate machines may aid weight loss and trim abdominal fat
4. Adolescent Growth Plate Injuries May Be Related to Overuse
5. T-System Releases Free Clinician Swine Flu Templates, Incorporating Updated CDC Interim Guidelines for Diagnosis and Treatment
6. Declines in Foodborne Illness Have Plateaued, Report Says
7. Americans United for Life Applauds Ruling Directing Missouri to Issue Choose Life Plate
8. Children's National Research Links Platelets to Sepsis-Related Organ Failure
9. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
10. No More Diets or Counting Calories; Perfect Plate Makes a Permanent Change
11. Bioreactors might solve blood-platelet supply problems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 1University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 3